Word: drugging
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...prospect of a multibillion-dollar blockbuster that could be even bigger than Viagra and its competitors combined. At a European conference for sexual medicine on Monday, a German pharmaceutical company presented results from a pivotal phase III clinical trial in North America and announced that it had found a drug that works. "We saw an increase in sexually satisfying events, an increase in desire and a decrease in distress. When we look at this against a backdrop of a common and distressing problem that affects 1 of 10 women and for which no treatment exists, well, we are feeling very...
...about a decade, roughly since the FDA approved Viagra for sexual dysfunction in men, drug companies have been searching for the female version of the little blue pill, a drug to cure what ails women like Wendy in bed. But what ails them - a psychiatric condition known as hypoactive sexual desire disorder (HSDD), defined as a distressing lack of sexual desire, absent other medical conditions - has been notoriously difficult to pin down. (See how to prevent illness...
...treat women's libidos, the German company's trial results have reignited a decade-long debate over the merit of the HSDD diagnosis - the most commonly diagnosed female sexual dysfunction - which some psychologists say is a made-up condition, promoted precisely for the service of moments like this: a drug-company rep at a conference on sex declaring that a treatment has been discovered...
...life stress and interpersonal relationships. Add to that a cultural milieu that at once promotes shame and ignorance about women's sexuality while wildly inflating their expectations for sex. In many cases, says Norsigian, the proper solution to a lack of sexual desire would involve a number of non-drug approaches, such as therapy, mind-body techniques and getting partners involved in the solution. "That could be equally successful while at the same time not exposing women to the [potential] long-term adverse effects of drugs," says Norsigian, who suggests testing drugs like flibanserin against drug-free therapies. "Moreover...
...treat female sexual dysfunction in postmenopausal women in Europe, but after being tested in women in the U.S., the FDA rejected P&G's fast-track request for approval in 2004, requesting more long-term safety data. And early trials of the experimental compound PT-141, a nasally inhaled drug that affects brain receptors for the hormone melanocortin, which plays a role in sexual arousal, raised concerns about its effect on blood pressure. A somewhat more promising contender is LibiGel, a testosterone gel made by Illinois-based BioSante Pharmaceuticals, which is in phase III clinical trials...